Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Veredus Laboratories' VereMERS Test; LabCorp's Luminex xTAG CYP2D6 Service

Premium

Veredus Laboratories recently introduced VereMERS, a lab-on-a-chip application capable of detecting from a sequence perspective the coronavirus that causes Middle East Respiratory Syndrome.

According to the Singaporean molecular diagnostics firm, VereMERS can identify the coronavirus that causes MERS using the company's automated platform, which integrates PCR and microarray technology. STMicroelectronics manufactures Veredus Labs' chips.

Veredus Labs' claims that it can deliver a result using its technology within two hours compared to other methods that can take up to several weeks. The company said that the assay will be eventually integrated into its existing VereFlu offering.


Laboratory Corporation of America announced recently that it is now offering drug metabolism testing using Luminex's xTAG CYP2D6 Kit.

CYP2D6 is one of the genes in the cytochrome P450 family of enzymes that is responsible for metabolizing many drugs. Genetic polymorphisms of CYP2D6 are associated with different drug metabolizing phenotypes and can be used to assess the potential for altered enzyme activity, LabCorp said.

The US Food and Drug Administration cleared Luminex's kit for clinical use earlier this year.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.